International journal of clinical pharmacy
-
Randomized Controlled Trial Multicenter Study Comparative Study
Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa.
There is lack of information on the efficacy and safety of piperacillin–tazobactam administered by continuous infusion. ⋯ Continuous infusion of piperacillin–tazobactam is an alternative administration drug method at least similar in efficacy and safety to conventional intermittent infusion. Multivariate analysis is needed to determine whether continuous administration might be more beneficial than intermittent in certain patient subgroups.